BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15478565)

  • 1. Demystifying CINV control in the complex aging patient: assessing the complexities of the aging oncology patient.
    ONS News; 2004; 19(9 Suppl):5-8. PubMed ID: 15478565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced nausea and vomiting (CINV): prevention, detection, and treatment--how are we doing?
    ONS News; 2004; 19(9 Suppl):61-2. PubMed ID: 15478591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced nausea and vomiting (CINV): detection and management of postinfusion CINV--how are we doing?
    Padezanin S
    ONS News; 2006; 21(8 Suppl):43-4. PubMed ID: 16925147
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy-induced nausea and vomiting.
    Lohr L
    Cancer J; 2008; 14(2):85-93. PubMed ID: 18391612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
    Navari RM
    J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant.
    Sankhala KK; Pandya DM; Sarantopoulos J; Soefje SA; Giles FJ; Chawla SP
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1607-14. PubMed ID: 19929449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective interventions for CINV: NCCN Antiemesis Clinical Practice Guidelines in Oncology.
    ONS News; 2004; 19(9 Suppl):17-8. PubMed ID: 15478570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced nausea and vomiting: an overview and comparison of three consensus guidelines.
    Tageja N; Groninger H
    Postgrad Med J; 2016 Jan; 92(1083):34-40. PubMed ID: 26561590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of neurokinin-1 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy.
    Rogers MP; Blackburn L
    Clin J Oncol Nurs; 2010 Aug; 14(4):500-4. PubMed ID: 20682506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes.
    Hawkins R; Grunberg S
    Clin J Oncol Nurs; 2009 Feb; 13(1):54-64. PubMed ID: 19193549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomiting.
    Schwartzberg LS; Grunberg SM; Kris MG
    Clin Adv Hematol Oncol; 2011 Nov; 9(11 Suppl 27):1-14; quiz 15-6. PubMed ID: 22362372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical management of chemotherapy-induced nausea and vomiting.
    Wiser W; Berger A
    Oncology (Williston Park); 2005 Apr; 19(5):637-45. PubMed ID: 15945344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and emerging therapeutic options for the management of chemotherapy-induced nausea and vomiting.
    Schwartzberg LS; Rugo HS; Aapro MS
    Clin Adv Hematol Oncol; 2015 Mar; 13(3 Suppl 3):3-13, 1; quiz 2 p following 14. PubMed ID: 25856052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nurse-led evidence-based practice project to monitor and improve the management of chemotherapy-induced nausea and vomiting.
    Underhill ML; Chicko L; Berry DL
    Clin J Oncol Nurs; 2015 Feb; 19(1):38-40. PubMed ID: 25689647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.
    Slatkin NE
    J Support Oncol; 2007 May; 5(5 Suppl 3):1-9. PubMed ID: 17566383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing the value of novel therapies in chemotherapy-induced nausea and vomiting.
    Schwartzberg L
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):825-34. PubMed ID: 25227565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists.
    Gralla R
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):507-8. PubMed ID: 17147235
    [No Abstract]   [Full Text] [Related]  

  • 18. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.
    Antonarakis ES; Hain RD
    Arch Dis Child; 2004 Sep; 89(9):877-80. PubMed ID: 15321871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best practice management of CINV in oncology patients: I. Physiology and treatment of CINV. Multiple neurotransmitters and receptors and the need for combination therapeutic approaches.
    Frame DG
    J Support Oncol; 2010; 8(2 Suppl 1):5-9. PubMed ID: 20629452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy?
    Schwartzberg LS
    Oncology (Williston Park); 2007 Jul; 21(8):946-53; discussion 954, 959, 962 passim. PubMed ID: 17715696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.